G. S. Tarasovskiy

G. S. Tarasovskiy

Auto-generated profile, based on publicly available information

G. S. Tarasovskiy

FSBI «NMRC of cardiology named after academician E.I.Chazov» of the MH RF

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
OSO. V. Stukalova
O. V. Stukalova
NMN. A. Mironova
N. A. Mironova
MUM. D. Utsumueva
M. D. Utsumueva
SKS. Yu. Kashtanova
S. Yu. Kashtanova
EBE. A. Butorova
E. A. Butorova
STS. K. Ternovoy
S. K. Ternovoy
Aim. To assess the effect of the size and pattern of myocardial structural injury, determined by magnetic resonance imaging (MRI), on response to cardiac resynchronization therapy (CRT) in patients with ischemic and non-ischemic heart failure (HF).Material and methods. Forty seven patients with ischemic and non-ischemic HF (age 62,3±8,9 years (mean±SD), 44,6% females and 55,4% males), left ventricle (LV) ejection fraction 130 ms, and sinus rhythm were included in the study. Late-gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR) was undertaken to evaluate myocardial scar prior to CRT devices implantation. All CMR analysis was performed on CVI42 software. According to signal intensity, fibrosis zone and “grey zone” were defined for quantitative analysis (proportion and mass) of injury. Scar zone included fibrosis zone and “grey zone”. Scar location was assessed using a 16-segmentLV model. Response was defined as a reduction inLV end systolic volume of >15% at 6 months follow-up and HF functional class amelioration.Results. In nonresponse group there was significantly higher proportion and mass of total scar (median 4% [2,5; 19] vs 24% [7; 44], p=0,012,6 g [3,5; 32,5] vs41 g [8; 86], p=0,013)), fibrosis zone (median 0% [0; 3,5] vs 8% [0; 19], p=0,01,0 g [0; 6] vs14 g [0; 34], p=0,014) and “grey zone” (4% [2,5; 15] vs 15% [7; 23], p=0,018,6 g [3,5; 27,5] vs23 g [8; 39], p=0,25). Response proportion in non-ischemic HF patients was higher than in ischemic HF patients (78,5% vs 28,5%, p<0,01). Response to CRT was less in patients with posterolateral scar, more specifically in segments 4,5,6,11,12,15,16 (p<0,05). CRT response in ischemic HF did not depend on size of myocardial structural injury, but depend on scar localization. Lateral scar was associated with poor response. In non-ischemic HF, proportion and mass of fibrosis zone was less in responder group (median 0% [0; 1] vs 8,5% [0; 11], p<0,05,0 g [0; 1] vs14,5 g [0; 22], p<0,05.Conclusion. Response to CRT is significantly higher in non-ischemic than in ischemic HF patients. Nonresponse to CRT is associated with posterolateral scar, regardless of the HF origin. In patients with non-ischemic HF, size of fibrosis zone is lower in the responder group. In patients with ischemic HF, size ofLV structural injury does not affect the CRT efficiency, but lateral scar is associated with CRT nonresponse.

15 March 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ERElena M. Rimskaya
Elena M. Rimskaya
SDS. V. Dobrovolskaya
S. V. Dobrovolskaya
EKE. V. Kukharchuk
E. V. Kukharchuk
SKS. Yu. Kashtanova
S. Yu. Kashtanova
NMN. A. Mironova
N. A. Mironova
SGS. P. Golitsyn
S. P. Golitsyn
Aim. To evaluate myocardial function in different groups of patients with left bundle branch block (LBBB) and the LBBB "model" — right ventricular pacing (RVP).Material and methods. Global longitudinal strain (GLS) and myocardial function parameters, such as global constructive work (GCW), global wasted work (GWW), global work index (GWI), and global work efficiency (GWE), were measured in 25 patients with dilated cardiomyopathy (DCM) and LBBB (DCM-LBBB group), 20 patients with DCM and a narrow QRS complex (DCM-nonLBBB group), 15 patients with LBBB developed after transcatheter aortic valve implantation (TAVI LBBB group), 12 patients with idiopathic LBBB (I-LBBB group), 27 patients with permanent RVP, and 10 healthy volunteers (HVs). The segments with maximum and minimum GWI were determined in all patients.Results. The GLS, GWI and GCW values were comparable in the I-LBBB and RVP groups, and were significantly lower in the TAVI-LBBB and both DCM groups than in HVs (p=0,049, 0,006, 0,025; p<0,001, respectively). Patients in the I-LBBB, TAVI-LBBB, RVP and DCM-LBBB groups were characterized by an increased GWW value (261 [203,5; 291,5], 273 [184,8; 385,3] and 237 [149,5; 445,3] versus 108 [74,3; 137,3] mm Hg%, p=0,033, 0,006, <0,001, <0,001, respectively), while the GWW value in the DCM-LBBB group was the highest (346,5 [255,5; 437,8] mm Hg%). The GWW value was associated with the QRS width (r=0,456, p<0,001). The GWE value was reduced in the I-LBBB, TAVI-LBBB, RVP and DCM-LBBB groups compared to HVs (p=0,033, 0,007, 0,023, <0,001, respectively). The area of maximum GWI was located in the posterolateral wall, and the minimum GWI in the interventricular septum in most patients with LBBB, while in the RVP group it was very diverse.Conclusion. Despite the fact that all patients with an electrical activation pattern corresponding to LBBB are characterized by significant wasted work, its contribution to the global myocardial work is significant only in patients with DCM. Lost work does not lead to a decrease in constructive work in patients with I-LBBB and RVP and normal left ventricular systolic function.

28 June 2021 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NSN. B. Shlevkov
N. B. Shlevkov
AGA. Zh. Gasparyan
A. Zh. Gasparyan
AZA. A. Zhambeev
A. A. Zhambeev
HSH. F. Salami
H. F. Salami
EGE. V. Guseva
E. V. Guseva
SGS. P. Golitsyn
S. P. Golitsyn
Background: According to numerous studies, from 30% to 50% of patients with chronic heart failure (CHF) are resistant to cardiac resynchronization therapy (CRT) and cardiac contractility modulation (CCM), despite their careful selection in accordance with current guidelines. It is of interest to study neurohormones characterizing myocardial (NT-proBNP) and fibrosis (sST2) as potential additional markers of CHF patients' “response” to CRT and CCM.Aim: To evaluate the potential to use NT-proBNP and sST2 biomarkers in CHF patients combined with transthoracic echocardiography (Echo) and contrast magnetic resonance imaging (MRI) parameters of the heart to predict a positive response to CRT and CCM devices.Materials and methods: The study included 51 patients (41 men, 10 women) aged 58 ± 12 years (26 to 79 years) with ischemic heart disease post acute myocardial infarction (n = 22) or non-ischemic cardiomyopathy (n = 29), left ventricle (LV) ejection fraction (EF) < 35%, and CHF II–III NYHA functional class despite ≥ 3 months of optimized medical therapy. The patients were assessed by serum biomarkers NT-proBNP and sST2 measurements, transthoracic Echo, and contrast- enhanced cardiac MRI. After the diagnostic assessment, CRT defibrillators (CRT-D) were implanted to 39 patients and CCM to 12 patients. After prospective follow-up of the patients for 18 to 24 months, predictors of the response to each device type were analyzed in univariate, multivariate, and ROC analysis.Results: The response to CRT-D was found in 21 (54%) patients, to CCM in 7 (58%) patients. Multivariate analysis showed the following predictors of the response of patients to CRT-D were: 1) sST2 < 50 ng/mL, 2) NT-proBNP < 3900 pg/mL, 3) < 3 LV segments with fibrosis (by MRI) and 4) anteroposterior dimension of the left atrium < 4.8 cm (by Echo). Any 2 of these 4 characteristics made it possible to predict the response to CRT with an accuracy of 87% (sensitivity 90%, specificity 83%). The predictors of the response to CCM were: 1) sST2 < 30 ng/ml, 2) LV end diastolic diameter < 78 mm (Echo), 3) age < 56 years, 4) body mass index < 27 kg/m2. Any 2 of these 4 characteristics predicted the positive response to CCM with an accuracy of 92% (sensitivity 86%, specificity 100%).Conclusion: The preoperative sST2 level was the only universal marker of the response to either CRT (< 50 ng/mL) or CCM (< 30 ng/mL) devices in CHF patients with reduced LVEF. The results indicate the potential for improved efficacy of these devices with their earlier implantation after the onset of the heart disease, as well as provided that maximal control CHF in these patients has been achieved.

13 March 2024 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
GTG.S. Tarasovskiy
G.S. Tarasovskiy
NSN.B. Shlevkov
N.B. Shlevkov
TET.V. Ezhova
T.V. Ezhova
TMT.A. Malkina
T.A. Malkina
KBK.V. Belik
K.V. Belik
SGS.P. Golitsyn
S.P. Golitsyn
Currently, a remote monitoring system is recommended for more effective monitoring of patients with implanted cardioverter defibrillators (ICDs). OBJECTIVE To analyze the feasibility of remote monitoring system for prediction of ventricular tachyarrhythmias in patients with ICD. MATERIAL AND METHODS The study included 104 patients (69 men/35 women), aged 60±15 years with ischemic (n=73) or non-ischemic cardiomyopathy and sustained VT (n=86) throughout the follow-up period (median 41 months). We retrospectively assessed the following parameters 1, 2 and 4 weeks, as well as 3 months before each episode of VT using remote monitoring system: daily activity, mean heart rate, heart rate variability (SDNN), percentage of atrial and ventricular pacing, non-sustained and/or sustained (>30 sec) episodes of VT, atrial fibrillation and episodes of anti-tachycardia pacing/electroconvulsive therapy. Univariate, ROC and multivariate analyses identified the following parameters of remote monitoring system associated with VT: VT ≤180 beats/min and so-called «fast VT/VF» (VT >180 beats/min or ventricular fibrillation). The control group included patients without arrhythmic events (n=80). RESULTS VT type had no significant relationship with age and gender of patients, etiology of cardiomyopathy, antiarrhythmic therapy and follow-up, as well as parameters of remote monitoring system. Predictors of any VT: 1) ICD therapy within the last 3 months; 2) non-sustained VT over the past 3 months; 3) non-sustained VT over the past 7 days; 4) nighttime heart rate increase by more than 5 beats per minute during the last 7 days; 5) SDNN variations over the last 7 days. Identification of 3 out of 5 signs made it possible to predict VT with accuracy of 82% (sensitivity 90%, specificity 76%). CONCLUSION We developed an algorithm for prediction of VT using remote monitoring system. These results can be used for timely prescription or correction of antiarrhythmic and other therapy.

23 September 2026 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
KKK. N. Kozaeva
K. N. Kozaeva
ERElena M. Rimskaya
Elena M. Rimskaya
GTG. S. Tarasovskiy
G. S. Tarasovskiy
KSKh. F. Salamy
Kh. F. Salamy
VKV. G. Kiktev
V. G. Kiktev
СГС. П. Голицын
С. П. Голицын
Aim. To identify clinical and instrumental factors associated with clinical outcomes in patients with implanted implantable cardioverterdefibrillators (ICD) / cardiac resynchronization therapy defibrillators (CRTD). Material and methods. A singlecenter retrospective registry included clinical and instrumental data from 315 patients with an implanted ICD (n=208; 66.0%) or CRTD (n=107; 34.0%). Median age at implantation was 59 years (IQR 50-67); 74.6% were male. Coronary artery disease (CAD) was diagnosed in 131 patients (41.6%), dilated cardiomyopathy (DCM) in 112 (35.6%), and other heart diseases in 72 (22.9%). Device implantation was performed for primary prevention of sudden cardiac death (SCD) in 207 (65.7%) patients and for secondary prevention in 108 (34.3%). In patients with CRTD, the effect of therapy was prospectively assessed at 6-12 months. The study endpoints were: endpoint 1 (EP1) - appropriate ICD therapy; endpoint 2 (EP2) - electrical storm (ES); endpoint 3 (EP3) - death from any cause / heart transplantation / left ventricular assist device (LVAD) implantation. Median followup was 40.9 months (IQR 15.5-89.8 months). Results. EP1 - Data on device function were available for 278 of 315 patients; EP1 was reached in 89 (32.0%) of them. Independent factors for reaching EP1 were implantation for secondary prevention of SCD (OR 2.50; p=0.002) and CAD (OR 2.03; p=0.007). The rate of EP1 differed significantly among etiological groups (logrank p=0.003): 42.7% in CAD; 23.8% in DCM; and 26.9% in “Other” (χ²=9.78; p=0.008). In the CRT-D group, the risk of appropriate ICD therapy was lower than in the ICD group: 20.4% vs 38.3%, but did not reach statistical significance (HR 0.50 [0.25-1.01] p=0.054). EP2 was reached in 18 patients (5.7%). Due to the small number of events, no independent predictors of EP2 were identified. EP3 - Clinical status was known for 286 patients (90.8%). EP3 was reached in 24 patients (8.4%). The only independent factor associated with EP3 was NYHA functional class of chronic heart failure (OR 2.95; p=0.005). Etiology did not affect the occurrence of EP3 (logrank p=0.125). In 100 of 107 patients in the CRT-D group, significant left ventricular reverse remodelling was recorded as an increase in left ventricular (LV) ejection fraction (LVEF) from 27% to 40.5%, a decrease in LV enddiastolic volume by 58.5 mL and LV endsystolic volume by 59 mL (p<0.0001). A reduction in LV endsystolic volume of ≥15% during CRT was achieved in 66 (66%) patients. The rate of EP3 did not differ significantly between the ICD and CRTD groups (8.6% vs 8.0%; p=0.260). Conclusion. The severity of CHF (NYHA functional class) is the leading factor associated with death/transplantation/LVAD implantation, whereas CAD and implantation for secondary prevention of SCD were independent factors associated with appropriate ICD therapy.

8 May 2025 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
ERElena M. Rimskaya
Elena M. Rimskaya
SDSvetlana Е. Dobrovolskaya
Svetlana Е. Dobrovolskaya
GTGennady S. Tarasovskiy
Gennady S. Tarasovskiy
SKSvetlana Yu. Kashtanova
Svetlana Yu. Kashtanova
VSVictor N. Shitov
Victor N. Shitov
ГПГолицын Сергей Павлович
Голицын Сергей Павлович
Aim. To analyze myocardial work in cardiac resynchronization therapy (CRT) and to determine the factors influence its positive dynamics. Materials and methods. Global longitudinal strain (GLS) and myocardial work parameters including global constructive work (GCW), global wasted work (GWW), global work index (GWI) and global work efficiency (GWE) were analyzed in addition to standard transthoracic echocardiography (TTE) in 60 patients (mean age 61±10 years, 36 male) with left bundle branch block (LBBB), chronic heart failure (HF 2 [2; 3] FC (NYHA), decreased left ventricular ejection fraction (LF EF=28 [23; 31] %) before and 6 months after CRT implantation.. In all patients the segments with maximum and minimum WI value were determined and the difference in segments with maximal and minimal WI (Max-Min WI), as the indicator of myocardial work asymmetry was calculated. Results. CRT led to reverse cardiac remodeling in 44 (73.3%) patients; clinical stabilization without positive TTE dynamics – in 11 (18.3%) patients, worsening or death – in 5 (8.3%) patients. In both groups of reverse remodeling and clinical stabilization CRT resulted in GWW reduction and thus GWE and GWI enhancement. However, the decrease in GWW in these patients is not accompanied by an increase in GCW and GLS, in contrast to patients with reverse remodeling, who developed statistically significant change in GCW and GLS during CRT. Patients with worsening or death were characterized by a minimal decrease in GWW in CRT (62,0 [9,7; 133,7] vs 149,5 [92.8; 206,2] mmHg% in patients with reverse remodeling and clinical stabilization; p=0,035). Max-Min WI turned out to be directly related to the LV EF change in CRT (rxy=0,336; p=0,017) that makes this value to be one of possible predictors of reverse remodeling during CRT. Conclusion. Wasted myocardial work can serve a contractile reserve, which represent a target for CRT. Its mobilization and decrease can lead to stable clinical status in patients even in the absence of reverse myocardial remodeling.